Year All2024202320222021202020192018201720162015201420132012 ADMA Biologics to Participate in the Raymond James Institutional Investor Conference Mar 05, 2024 ADMA Biologics Announces CFO Transition Feb 28, 2024 ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update Feb 28, 2024 ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 Feb 21, 2024 ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics Feb 21, 2024 ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update Jan 08, 2024
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update Feb 28, 2024
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 Feb 21, 2024
ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update Jan 08, 2024
